GovChime
Notice ID: 5f843004e5a54f83afa78a2d3feb9ff9Award NoticeAwarded

6505--ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063

Awarded on August 5, 2026. Full description on SAM.gov.

Awarded tounder 36F79720D018036C25526N0394 (source: SAM.gov award notice)• $891.6K

Description

Ordering Activity / Contracting Office Department of Veterans Affairs Network Contracting Office (NCO 15) 3450 S 4th Street Trafficway Leavenworth, KS 66048 Contract / Order Information FSS Contract Number: 36F79720D0180 Order Number: 36C25526N0394 Requisition / PO Number: 657-C60305 Effective Date of Award: August 5, 2026Ordering Period: August 5, 2026 through February 5, 2027 Method of Solicitation: FSS order under SF 1449, commercial products and commercial services Awardee (Contractor) Novartis Pharmaceuticals Corporation 59 Route 10 East Hanover, NJ 07936 UEI: NG61ZA8TADW3 (as shown on the SF 1449). Primary Contractor POC: Yisell Rodriguez, 201 602 5055, yisell.rodriquez@novartis.com. Place of Delivery / Performance VA St. Louis Health Care System John J. Cochran Veterans Hospital 915 North Grand Boulevard St. Louis, MO 63106 Description of Supplies/Services This award provides one proprietary radiopharmaceutical agent, PLUVICTO (Lutetium Lu 177 vipivotide tetraxetan), NDC 69488 0010 6, for use by Nuclear Medicine at VA St. Louis Health Care System. PLUVICTO is indicated for adult patients with PSMA positive metastatic castration resistant prostate cancer who have been treated with androgen receptor pathway inhibition and taxane based chemotherapy. The period of performance supports diagnostic and therapeutic use of this radiopharmaceutical in accordance with the Statement of Work included in the SF 1449. Line Item and Pricing CLIN 0001: PLUVICTO Lutetium Lu 177 vipivotide tetraxetan, NDC 69488 0010 6. Quantity: 26 Each. Unit Price: 34,294.26. Extended Amount: 891,650.76. Total Award Amount: 891,650.76. Funding / Accounting Data As shown on SF 1449: 657 26 4 1642 0063 / 657 3660 / 160 1642 822900 2580 / 0100L00H6 (Accounting and Appropriation Data). Invoice and Payment Instructions Invoices shall be submitted monthly in arrears and must reference PO number 657 C60305 and Order number 36C25526N0394. All invoices shall be submitted electronically in accordance with VAAR 852.232 72, via the VA Financial Services Center e-invoicing system (Austin, TX). Payment will be made by: Department of Veterans Affairs Financial Services Center, Austin, TX (see SF 1449 Block 18a and Continuation Page for full details). Contract Administration / Points of Contact Contracting Officer: Michael P. Murphy Department of Veterans Affairs Network Contracting Office (NCO 15) 3450 S 4th Street Trafficway, Leavenworth, KS 66048 Email: michael.murphy7@va.gov Phone: 913 946 1970 Facility Point of Contact (Pluvicto): Mark Lauridsen VA St. Louis Health Care System Email: mark.lauridsen@va.gov Phone: 314 652 4100 ext. 66522 The Contracting Officer retains sole authority to approve changes or modifications affecting price, quantity, or quality of performance under this contract. The Contracting Officer s Representative (COR) will be designated separately in accordance with VAAR 852.270 1 and will be responsible for technical and administrative oversight. Special Terms and Conditions This order is subject to the terms and conditions of FSS Contract 36F79720D0180 and all clauses incorporated by reference on SF 1449, including VAAR 852.247 71 (Delivery Location), VAAR 852.232 72 (Electronic Submission of Payment Requests), VAAR 852.203 70 (Commercial Advertising), VAAR 852.242 71 (Administrative Contracting Officer), and VAAR 852.246 71 (Rejected Goods). The VA St. Louis Health Care System s business hours and applicable federal holidays are as set forth in the Statement of Work, and contract performance monitoring will be conducted in accordance with VA quality assurance procedures described therein.

Full description on SAM.gov

Overview

Agency:
Department of Veterans Affairs
Office:255-NETWORK CONTRACT OFFICE 15 (36C255)
Posted:August 21, 2026
NAICS:325412: Pharmaceutical Preparation Manufacturing
Last Updated:Oct 22, 2026
First published:
Last updated on SAM.gov:
PSC:6505: DRUGS AND BIOLOGICALS
Set-Aside:Not specified
Type:Award Notice
Place of Performance:Not specified
Award Date:Aug 5, 2026
Award Amount (SAM.gov award notice):$891.6K

Award Overview

Award Number

36F79720D018036C25526N0394

Award Amount (SAM.gov award notice)

$891.6K

Award Date

Aug 5, 2026

Awardee

Awardee UEI

NG61ZA8TADW3

Awardee CAGE Code

04520

Awardee Address

EAST HANOVER, NJ 07936, NJUNI

Original Solicitation

Notice ID: 5f843004e5a54f83afa78a2d3feb9ff9

Posted Date: Aug 21, 2026

Original Response Deadline: Not specified

Contract Details

Contract data not yet available

Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.

Contacts

Contracting Officer

Primary Contact

Michael P Murphy
Michael Murphy

Documents

Files (1)

  • 36F79720D0180 36C25526N0394_1.docx

    19 KBAdded in Award Notice version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Award NoticeArchivedCurrent

    6505--ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063

    Notice 5f843004e5a54f83afa78a2d3feb9ff9 on SAM.gov

Similar Opportunities

Title
Phase
Agency
NAICS
Set Aside
Posted
Deadline
Location

Additional Details

Solicitation Number

36C25526N0394

Archive Date

Oct 20, 2026

Office Address

LEAVENWORTH, KS, 66048